TGR5 in the Cholangiociliopathies

Area of Science:

• Hepatology
• Cell Biology
• Gastroenterology

Background:

• TGR5 (Takeda G protein-coupled receptor 5) is a bile acid-activated receptor expressed in cholangiocytes.
• TGR5 signaling influences cellular responses, primarily through the cAMP pathway.
• Cholangiopathies, including polycystic liver disease (PLD), involve biliary duct abnormalities.

Purpose of the Study:

• To investigate the role of TGR5 in hepatic cystogenesis in PLD.
• To determine if TGR5-mediated cAMP signaling contributes to the proliferation of cystic cholangiocytes.

Main Methods:

• Analysis of TGR5 expression and localization in human and rodent cholangiocytes, including those from cystic livers.
• Assessment of cellular responses (cAMP levels, proliferation) to TGR5 activation in ciliated and non-ciliated cholangiocytes.
• Evaluation of hepatic cystogenesis in a TGR5-deficient animal model of PLD.

Main Results:

• TGR5 is overexpressed and mislocalized in cystic cholangiocytes.
• TGR5 activation in cystic cholangiocytes leads to increased cAMP, hyperproliferation, and cyst growth.
• Genetic deletion of TGR5 significantly inhibited hepatic cystogenesis in a PLD animal model.

Conclusions:

• TGR5 plays a critical role in the development and progression of PLD.
• TGR5-mediated cAMP signaling in cystic cholangiocytes drives hepatic cystogenesis.
• Targeting TGR5 in cystic cholangiocytes presents a potential therapeutic strategy for PLD.